All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.

Kao, Jia-Horng

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver 10 2016 - 1433-41 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

1478-3231

10.1111/liv.13128 doi


Administration, Oral
Adult
Aged
Alanine Transaminase--blood
Antiviral Agents--administration & dosage
Asian People
Carbamates
Double-Blind Method
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--administration & dosage
International Cooperation
Isoquinolines--administration & dosage
Logistic Models
Male
Middle Aged
Multivariate Analysis
Pyrrolidines
RNA, Viral--blood
Sulfonamides--administration & dosage
Sustained Virologic Response
Valine--analogs & derivatives
Viral Load
Viral Nonstructural Proteins--genetics